Published in Lancet on January 02, 1982
Muscle pain and wasting in osteomalacia. J R Soc Med (1985) 0.75
A report--chronic fatigue syndrome: guidelines for research. J R Soc Med (1991) 7.70
Understanding face recognition. Br J Psychol (1986) 7.65
The expression of vesicular glutamate transporters defines two classes of excitatory synapse. Neuron (2001) 4.97
Human skeletal muscle function: description of tests and normal values. Clin Sci Mol Med (1977) 4.71
Cloning of the cellular receptor for amphotropic murine retroviruses reveals homology to that for gibbon ape leukemia virus. Proc Natl Acad Sci U S A (1994) 4.67
Predicted normal values for maximal respiratory pressures in caucasian adults and children. Thorax (1984) 4.42
Identification and characterization of the vesicular GABA transporter. Nature (1997) 4.26
Pericentrin and gamma-tubulin form a protein complex and are organized into a novel lattice at the centrosome. J Cell Biol (1998) 4.23
An increasing work rate test for assessing the physiological strain of submaximal exercise. Clin Sci Mol Med (1974) 3.73
Uptake of glutamate into synaptic vesicles by an inorganic phosphate transporter. Science (2000) 3.68
A genome-wide search for quantitative trait loci underlying asthma. Nature (1996) 3.58
Implications of socio-cultural contexts for the ethics of clinical trials. Health Technol Assess (1997) 3.57
Cloning of a delta opioid receptor by functional expression. Science (1992) 3.49
The BILAG index: a reliable and valid instrument for measuring clinical disease activity in systemic lupus erythematosus. Q J Med (1993) 3.35
An analysis of the physiological strain of submaximal exercise in patients with chronic obstructive bronchitis. Thorax (1975) 3.13
Malignant lymphoma in primary Sjögren's syndrome: a multicenter, retrospective, clinical study by the European Concerted Action on Sjögren's Syndrome. Arthritis Rheum (1999) 2.99
Fatigue of long duration in human skeletal muscle after exercise. J Physiol (1977) 2.98
Idiotypic cross-reactions of monoclonal human lupus autoantibodies. J Exp Med (1983) 2.96
Ultrastructural changes after concentric and eccentric contractions of human muscle. J Neurol Sci (1983) 2.86
The vesicular GABA transporter, VGAT, localizes to synaptic vesicles in sets of glycinergic as well as GABAergic neurons. J Neurosci (1998) 2.76
Therapeutic benefit of blocking interleukin-6 activity with an anti-interleukin-6 receptor monoclonal antibody in rheumatoid arthritis: a randomized, double-blind, placebo-controlled, dose-escalation trial. Arthritis Rheum (2002) 2.75
The cost-effectiveness of infliximab (Remicade) in the treatment of rheumatoid arthritis in Sweden and the United Kingdom based on the ATTRACT study. Rheumatology (Oxford) (2003) 2.69
Adult- and childhood-onset systemic lupus erythematosus: a comparison of onset, clinical features, serology, and outcome. Br J Rheumatol (1995) 2.69
Screening for diabetes in general practice: cross sectional population study. BMJ (2001) 2.64
A cDNA that suppresses MPP+ toxicity encodes a vesicular amine transporter. Cell (1992) 2.58
Evidence for linkage of a candidate chromosome 1 region to human systemic lupus erythematosus. J Clin Invest (1997) 2.57
Strength, power and related functional ability of healthy people aged 65-89 years. Age Ageing (1994) 2.55
Muscle protein synthesis measured by stable isotope techniques in man: the effects of feeding and fasting. Clin Sci (Lond) (1982) 2.53
Relationship between colonial morphology and adherence of Streptococcus pneumoniae. Infect Immun (1995) 2.50
Expression of the Epstein-Barr virus latent membrane protein 1 induces B cell lymphoma in transgenic mice. Proc Natl Acad Sci U S A (1998) 2.49
The reliability of the Systemic Lupus International Collaborating Clinics/American College of Rheumatology Damage Index in patients with systemic lupus erythematosus. Arthritis Rheum (1997) 2.49
Normal muscle strength and fatigability in patients with effort syndromes. BMJ (1988) 2.46
Why we should not seek individual informed consent for participation in health services research. J Med Ethics (2002) 2.40
bcl-2 inhibits death of central neural cells induced by multiple agents. Proc Natl Acad Sci U S A (1993) 2.39
Expression of a putative vesicular acetylcholine transporter facilitates quantal transmitter packaging. Neuron (1997) 2.37
Ankylosing spondylitis in West Africans--evidence for a non-HLA-B27 protective effect. Ann Rheum Dis (1997) 2.33
Current evidence for the induction of autoimmune rheumatic manifestations by cytokine therapy. Arthritis Rheum (2000) 2.28
The Systemic Lupus International Collaborating Clinics/American College of Rheumatology (SLICC/ACR) Damage Index for Systemic Lupus Erythematosus International Comparison. J Rheumatol (2000) 2.26
The synaptic vesicle protein SV2 is a novel type of transmembrane transporter. Cell (1992) 2.25
Pain and fatigue after concentric and eccentric muscle contractions. Clin Sci (Lond) (1983) 2.24
Culture and somatization: clinical, epidemiological, and ethnographic perspectives. Psychosom Med (1998) 2.18
Auto-activation of the rta gene of human herpesvirus-8/Kaposi's sarcoma-associated herpesvirus. J Gen Virol (2000) 2.17
Implantation metastasis as a cause of local recurrence of colorectal carcinoma. Am J Surg (1989) 2.11
Mixed connective tissue disease--goodbye to all that. Br J Rheumatol (1992) 2.11
Leukocytes infiltrate the myometrium during human parturition: further evidence that labour is an inflammatory process. Hum Reprod (1999) 2.09
Development and assessment of a computerized index of clinical disease activity in systemic lupus erythematosus. Members of the British Isles Lupus Assessment Group (BILAG). Q J Med (1988) 2.09
Anti-DNA antibody idiotypes in systemic lupus erythematosus. Lancet (1984) 2.08
Framework for medical assessment of functional performance. Lancet (1990) 2.08
Screening a large reference sample to identify very low frequency sequence variants: comparisons between two genes. Nat Genet (2001) 2.07
VN training scheme. Vet Rec (2001) 2.04
Clinical use of nuclear magnetic resonance in the investigation of myopathy. Lancet (1982) 2.02
The contribution of reflex inhibition to arthrogenous muscle weakness. Clin Sci (Lond) (1984) 2.01
Symptom attribution in cultural perspective. Can J Psychiatry (1994) 1.98
Proposed preliminary core set measures for disease outcome assessment in adult and juvenile idiopathic inflammatory myopathies. Rheumatology (Oxford) (2001) 1.96
Metabolic changes associated with the slowing of relaxation in fatigued mouse muscle. J Physiol (1975) 1.95
Familial dependence of the resting metabolic rate. N Engl J Med (1986) 1.94
Exertion of stairclimbing in normal subjects and in patients with chronic obstructive bronchitis. Thorax (1977) 1.92
Size and strength of the quadriceps muscles of old and young women. Eur J Clin Invest (1984) 1.89
Insulinotropic actions of exendin-4 and glucagon-like peptide-1 in vivo and in vitro. Metabolism (2001) 1.87
Photophysics of the carotenoids associated with the xanthophyll cycle in photosynthesis. Photosynth Res (1994) 1.85
The gay report on sexually transmitted diseases. Am J Public Health (1981) 1.85
Raised serum IgG and IgA antibodies to mycobacterial antigens in rheumatoid arthritis. Ann Rheum Dis (1989) 1.85
Fourteen-year follow-up of children with and without speech/language impairments: speech/language stability and outcomes. J Speech Lang Hear Res (1999) 1.84
Vesicular transport regulates monoamine storage and release but is not essential for amphetamine action. Neuron (1997) 1.83
B-cell depletion in the treatment of patients with systemic lupus erythematosus: a longitudinal analysis of 24 patients. Rheumatology (Oxford) (2005) 1.83
Randomised controlled trial of patient education to encourage graded exercise in chronic fatigue syndrome. BMJ (2001) 1.82
The measurement of muscle strength in patients with peripheral neuromuscular disorders. J Neurol Neurosurg Psychiatry (1983) 1.82
Molecular cloning and partial sequencing of hepatitis A viral cDNA. J Virol (1985) 1.82
Synaptic vesicle transporter expression regulates vesicle phenotype and quantal size. J Neurosci (2000) 1.81
Effects of resistance training on strength, power, and selected functional abilities of women aged 75 and older. J Am Geriatr Soc (1995) 1.81
Neuromelanin biosynthesis is driven by excess cytosolic catecholamines not accumulated by synaptic vesicles. Proc Natl Acad Sci U S A (2000) 1.81
Respiratory arrest: a complication of cerebellar ectopia in adults. J Neurol Neurosurg Psychiatry (1988) 1.81
The size and strength of the quadriceps muscles of old and young men. Clin Physiol (1985) 1.80
Molecular analysis of system N suggests novel physiological roles in nitrogen metabolism and synaptic transmission. Cell (1999) 1.79
The time course of phosphorylcreatine resynthesis during recovery of the quadriceps muscle in man. Pflugers Arch (1976) 1.78
Large delayed plasma creatine kinase changes after stepping exercise. Muscle Nerve (1983) 1.76
Binding of cytoskeletal proteins by monoclonal anti-DNA lupus autoantibodies. Clin Immunol Immunopathol (1984) 1.76
Differential expression of two vesicular monoamine transporters. J Neurosci (1995) 1.75
Central and peripheral fatigue in sustained maximum voluntary contractions of human quadriceps muscle. Clin Sci Mol Med (1978) 1.74
Practical problems in the respiratory care of patients with muscular dystrophy. N Engl J Med (1987) 1.74
Percutaneous needle-biopsy of skeletal muscle in diagnosis and research. Lancet (1971) 1.72
Conchotome and needle percutaneous biopsy of skeletal muscle. J Neurol Neurosurg Psychiatry (1987) 1.72
Useful laboratory measurements in the management of systemic lupus erythematosus. Q J Med (1982) 1.68
Effect of temperature on muscle energy metabolism and endurance during successive isometric contractions, sustained to fatigue, of the quadriceps muscle in man. J Physiol (1972) 1.68
Excitation frequency and muscle fatigue: mechanical responses during voluntary and stimulated contractions. Exp Neurol (1979) 1.68
Sequence variation in the Epstein-Barr virus latent membrane protein 1. J Gen Virol (1994) 1.67
Quantification of walking mobility in neurological disorders. QJM (2004) 1.67
HLA and rheumatoid arthritis: a combined analysis of 440 British patients. Ann Rheum Dis (1986) 1.66
Repeatability of physical signs in airways obstruction. Thorax (1969) 1.65
B cell depletion therapy in systemic lupus erythematosus: effect on autoantibody and antimicrobial antibody profiles. Arthritis Rheum (2006) 1.65
Evidence for an association between rheumatoid arthritis and autoimmune endocrine disease. Ann Rheum Dis (1983) 1.64
Needle biopsy of skeletal muscle in the diagnosis of myopathy and the clinical study of muscle function and repair. N Engl J Med (1980) 1.64
Human IgG anti-DNA antibodies deposit in kidneys and induce proteinuria in SCID mice. Kidney Int (1995) 1.63
Hypoxemia during sleep in Duchenne muscular dystrophy. Am Rev Respir Dis (1988) 1.63
Rapid detection of cytomegalovirus by tissue culture, centrifugation, and immunofluorescence with a monoclonal antibody to an early nuclear antigen. J Virol Methods (1987) 1.63
Associates of health status in patients with systemic lupus erythematosus. J Rheumatol (1999) 1.62
B cell depletion therapy in systemic lupus erythematosus: relationships among serum B lymphocyte stimulator levels, autoantibody profile and clinical response. Ann Rheum Dis (2007) 1.62
A review of gastrointestinal manifestations of systemic lupus erythematosus. Rheumatology (Oxford) (1999) 1.60